Big Move For Castle Biosciences, Inc.
Castle Biosciences, Inc. (CSTL:NASDAQ) soared at $20.3, representing a gain of 52.9%. On Fri, Jul 07, 2023, CSTL:NASDAQ hit a New 2-Week High of $20.3. The stock appeared on our News Catalysts scanner on Fri, Jul 07, 2023 at 07:43 AM in the 'BIOTECH' category. From Fri, Jun 23, 2023, the stock recorded 66.67% Up Days and 60.00% Green Days
About Castle Biosciences, Inc. (CSTL:NASDAQ)
Castle Biosciences Inc is a United States-based company engaged in developing and commercializing diagnosis and prognostic tests for dermatologic cancers. Its non-invasive products utilize algorithms to provide an assessment of a patient's specific risk of metastasis or recurrence of their cancer. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Top 10 Gainers:
- Prestige Wealth Inc. (PWM:NASDAQ), 281.8%
- Gorilla Technology Group Inc. (GRRR:NASDAQ), 124.88%
- Vinco Ventures Inc. (BBIG:NASDAQ), 56.67%
- Castle Biosciences, Inc. (CSTL:NASDAQ), 52.86%
- Near Intelligence Inc Com (NIR:NASDAQ), 51.26%
- Galata Acquisition Corp. Class A (GLTA:NYSEMKT), 49.95%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 49.06%
- T2 Biosystems, Inc. (TTOO:NASDAQ), 38.55%
- The Real Good Food Company Inc. (RGF:NASDAQ), 34.25%
- Greenidge Generation Holdings Inc. (GREE:NASDAQ), 33.59%